Vertigo and Dizziness from Environmental Motion: Visual Vertigo, Motion Sickness, and Drivers' Disorientation

Adolfo M. Bronstein; John F. Golding; Michael A. Gresty

doi:10.1055/s-0033-1354602

Seminars in Neurology, Table of Contents

Semin Neurol 2013; 33(03): 219-230
DOI: 10.1055/s-0033-1354602

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Vertigo and Dizziness from Environmental Motion: Visual Vertigo, Motion Sickness, and Drivers' Disorientation

Adolfo M. Bronstein

¹Division of Brain Sciences, Department of Neurology, Imperial College London, Charing Cross Hospital, London, United Kingdom

,

John F. Golding

²Department of Psychology, University of Westminster, London, United Kingdom

,

Michael A. Gresty

¹Division of Brain Sciences, Department of Neurology, Imperial College London, Charing Cross Hospital, London, United Kingdom

› Author Affiliations

Abstract

The normal vestibular system may be adversely affected by environmental challenges which have characteristics that are unfamiliar or ambiguous in the patterns of sensory stimulation they provide. A disordered vestibular system lends susceptibility even to quotidian environmental experiences as the sufferer becomes dependent on potentially misleading, nonvestibular sensory stimuli. In both cases, the sequelae may be vertigo, incoordination, imbalance, and unpleasant autonomic responses. Common environmental motion conditions include visual vertigo, motion sickness, and motorists' disorientation. The core therapy for visual vertigo, motion sickness, and drivers' disorientation is progressive desensitization within a cognitive framework of reassurance and explanation, plus anxiolytic tactics and autogenic control of autonomic symptoms.

Keywords

motion sickness - vestibular - visual motion - driving

Full Text

References

References
1 Seemungal BM, Glasauer S, Gresty MA, Bronstein AM. Vestibular perception and navigation in the congenitally blind. J Neurophysiol 2007; 97 (6) 4341-4356
2 Okada T, Grunfeld E, Shallo-Hoffmann J, Bronstein AM. Vestibular perception of angular velocity in normal subjects and in patients with congenital nystagmus. Brain 1999; 122 (Pt 7) 1293-1303
3 Grunfeld EA, Shallo-Hoffmann JA, Cassidy L , et al. Vestibular perception in patients with acquired ophthalmoplegia. Neurology 2003; 60 (12) 1993-1995
4 Hoffman RA, Brookler KH. Underrated neurotologic symptoms. Laryngoscope 1978; 88 (7 Pt 1) 1127-1138
5 Hood JD. Unsteadiness of cerebellar origin: an investigation into its cause. J Laryngol Otol 1980; 94 (8) 865-876
6 Bronstein AM. Under-rated neuro-otological symptoms: Hoffman and Brookler 1978 revisited. Br Med Bull 2002; 63: 213-221
7 Longridge NS, Mallinson AI, Denton A. Visual vestibular mismatch in patients treated with intratympanic gentamicin for Meniere's disease. J Otolaryngol 2002; 31 (1) 5-8
8 Jacob RG. Panic disorder and the vestibular system. Psychiatr Clin North Am 1988; 11 (2) 361-374
9 Bronstein AM. Visual vertigo syndrome: clinical and posturography findings. J Neurol Neurosurg Psychiatry 1995; 59 (5) 472-476
10 Guerraz M, Yardley L, Bertholon P , et al. Visual vertigo: symptom assessment, spatial orientation and postural control. Brain 2001; 124 (Pt 8) 1646-1656
11 Pavlou M, Davies RA, Bronstein AM. The assessment of increased sensitivity to visual stimuli in patients with chronic dizziness. J Vestib Res 2006; 16 (4-5) 223-231
12 Furman JM, Jacob RG. Psychiatric dizziness. Neurology 1997; 48 (5) 1161-1166
13 Brandt T. Phobic postural vertigo. Neurology 1996; 46 (6) 1515-1519
14 Brandt T, Gresty MA, Luxon LM, Ron MA, Rudge P, Yardley L. Phobic postural vertigo. Neurology 1997; 49: 1480-1481
15 Page NG, Gresty MA. Motorist's vestibular disorientation syndrome. J Neurol Neurosurg Psychiatry 1985; 48 (8) 729-735
16 Cawthorne T. The rationale of physiotherapy in vertigo and facial palsy. Physiotherapy 1952; 38 (12) 237-241
17 Black FO, Pesznecker SC. Vestibular adaptation and rehabilitation. Curr Opin Otolaryngol Head Neck Surg 2003; 11 (5) 355-360
18 Pavlou M, Shummway-Cook A, Horak F, Yardley L, Bronstein AM. Rehabilitation of balance disorders in the patient with vestibular pathology. In: Bronstein AM, Brandt T, Woollacott M, Nutt J, , eds. Clinical Disorders of Balance and Gait Disorders. London, England: Edward Arnold; 2004: 317-343
19 Bronstein AM, Lempert T. Dizziness: A Practical Approach to Diagnosis and Management. Cambridge Clinical Guides.: Cambridge, England: Cambridge University Press; 2002
20 Vitte E, Sémont A, Berthoz A. Repeated optokinetic stimulation in conditions of active standing facilitates recovery from vestibular deficits. Exp Brain Res 1994; 102 (1) 141-148
21 Pavlou M, Lingeswaran A, Davies RA, Gresty MA, Bronstein AM. Simulator based rehabilitation in refractory dizziness. J Neurol 2004; 251 (8) 983-995
22 Stern RM, Koch KL, Leibowitz HW, Lindblad IM, Shupert CL, Stewart WR. Tachygastria and motion sickness. Aviat Space Environ Med 1985; 56 (11) 1074-1077
23 Benson AJ. Motion sickness. In: Pandolf K, Burr R, , eds. Medical Aspects of Harsh Environments. Vol. 2. Washington, DC: Walter Reed Army Medical Center; 2002: 1048-1083
24 Eversmann T, Gottsmann M, Uhlich E, Ulbrecht G, von Werder K, Scriba PC. Increased secretion of growth hormone, prolactin, antidiuretic hormone, and cortisol induced by the stress of motion sickness. Aviat Space Environ Med 1978; 49 (1 Pt 1) 53-57
25 Golding JF. Phasic skin conductance activity and motion sickness. Aviat Space Environ Med 1992; 63 (3) 165-171
26 Cheung B, Nakashima AM, Hofer KD. Various anti-motion sickness drugs and core body temperature changes. Aviat Space Environ Med 2011; 82 (4) 409-415
27 Hettinger LJ, Kennedy RS, McCauley ME. Motion and human performance. In: Crampton GH, , ed. Motion and Space Sickness. Boca Raton, FL: CRC Press; 1990: 412-441
28 Heer M, Paloski WH. Space motion sickness: incidence, etiology, and countermeasures. Auton Neurosci 2006; 129 (1-2) 77-79
29 Reason JT, Brand JJ. Motion sickness. London: Academic Press; 1975
30 Bos JE, Bles W. Modelling motion sickness and subjective vertical mismatch detailed for vertical motions. Brain Res Bull 1998; 47 (5) 537-542
31 Bubka A, Bonato F, Urmey S, Mycewicz D. Rotation velocity change and motion sickness in an optokinetic drum. Aviat Space Environ Med 2006; 77 (8) 811-815
32 Stott JRR. Mechanisms and treatment of motion illness. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG, , ed. Nausea and Vomiting: Mechanisms and Treatment. Berlin, Germany: Springer-Verlag; 1986: 110-129
33 Treisman M. Motion sickness: an evolutionary hypothesis. Science 1977; 197 (4302) 493-495
34 Morrow GR. The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 1985; 55 (12) 2766-2770
35 Money KE, Cheung BS. Another function of the inner ear: facilitation of the emetic response to poisons. Aviat Space Environ Med 1983; 54 (3) 208-211
36 Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998; 47 (5) 395-406
37 Guedry FE, Rupert AR, Reschke MF. Motion sickness and development of synergy within the spatial orientation system. A hypothetical unifying concept. Brain Res Bull 1998; 47 (5) 475-480
38 Balaban CD. Vestibular autonomic regulation (including motion sickness and the mechanism of vomiting). Curr Opin Neurol 1999; 12 (1) 29-33
39 Reavley CM, Golding JF, Cherkas LF, Spector TD, MacGregor AJ. Genetic influences on motion sickness susceptibility in adult women: a classical twin study. Aviat Space Environ Med 2006; 77 (11) 1148-1152
40 Turner M, Griffin MJ. Motion sickness in public road transport: passenger behavior and susceptibility. Ergonomics 1999; 42 (3) 444-461
41 Kennedy RS, Lanham DS, Massey CJ, Drexler JM. Gender differences in simulator sickness incidence: implications for military virtual reality systems. SAFE J 1995; 25: 69-76
42 Lawther A, Griffin MJ. A survey of the occurrence of motion sickness amongst passengers at sea. Aviat Space Environ Med 1988; 59 (5) 399-406
43 Golding JF, Kadzere PN, Gresty MA. Motion sickness susceptibility fluctuates through the menstrual cycle. Aviat Space Environ Med 2005; 76 (10) 970-973
44 Golding JF. Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness. Brain Res Bull 1998; 47 (5) 507-516
45 Johnson WH, Sunahara FA, Landolt JP. Importance of the vestibular system in visually induced nausea and self-vection. J Vestib Res 1999; 9 (2) 83-87
46 Drummond PD. Effect of tryptophan depletion on symptoms of motion sickness in migraineurs. Neurology 2005; 65 (4) 620-622
47 Boldingh MI, Ljøstad U, Mygland A, Monstad P. Vestibular sensitivity in vestibular migraine: VEMPs and motion sickness susceptibility. Cephalalgia 2011; 31 (11) 1211-1219
48 Golding JF. Predicting individual differences in motion sickness susceptibility by questionnaire. Pers Individ Dif 2006; 41: 237-248
49 Whittle J. An exact diary of the late expedition of his illustrious highness the Prince of Orange, 1689. Cited in: Pike J. Tall Ships in Torbay: a Brief Maritime History. Bradford on Avon, Wilts, UK: Ex Libris Press; 1986: 35
50 Nachum Z, Shupak A, Letichevsky V , et al. Mal de debarquement and posture: reduced reliance on vestibular and visual cues. Laryngoscope 2004; 114 (3) 581-586
51 Murdin L, Golding J, Bronstein A. Managing motion sickness. BMJ 2011; 343: 1213-1217
52 Cha YH. Mal de debarquement. Semin Neurol 2009; 29 (5) 520-527
53 Cowings PS, Toscano WB. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms. J Clin Pharmacol 2000; 40 (10) 1154-1165
54 Benson AJ. Motion sickness. In: Ernsting J, Nicholson AN, Rainford DS, , eds. Aviation Medicine. Oxford, England: Butterworth Ltd; 1999
55 Yen Pik Sang F, Billar J, Gresty MA, Golding JF. Effect of a novel motion desensitization training regime and controlled breathing on habituation to motion sickness. Percept Mot Skills 2005; 101 (1) 244-256
56 Wood CD, Manno JE, Manno BR, Odenheimer RC, Bairnsfather LE. The effect of antimotion sickness drugs on habituation to motion. Aviat Space Environ Med 1986; 57 (6) 539-542
57 van Marion WF, Bongaerts MC, Christiaanse JC, Hofkamp HG, van Ouwerkerk W. Influence of transdermal scopolamine on motion sickness during 7 days' exposure to heavy seas. Clin Pharmacol Ther 1985; 38 (3) 301-305
58 Golding JF, Bles W, Bos JE, Haynes T, Gresty MA. Motion sickness and tilts of the inertial force environment: active suspension systems vs. active passengers. Aviat Space Environ Med 2003; 74 (3) 220-227
59 Wada T, Konno H, Fujisawa S, Doi S. Can passengers' active head tilt decrease the severity of carsickness? Effect of head tilt on severity of motion sickness in a lateral acceleration environment. Hum Factors 2012; 54 (2) 226-234
60 Golding JF, Markey HM, Stott JRR. The effects of motion direction, body axis, and posture on motion sickness induced by low frequency linear oscillation. Aviat Space Environ Med 1995; 66 (11) 1046-1051
61 Rolnick A, Lubow RE. Why is the driver rarely motion sick? The role of controllability in motion sickness. Ergonomics 1991; 34 (7) 867-879
62 Bos JE, MacKinnon SN, Patterson A. Motion sickness symptoms in a ship motion simulator: effects of inside, outside, and no view. Aviat Space Environ Med 2005; 76 (12) 1111-1118
63 Yen Pik Sang FD, Billar JP, Golding JF, Gresty MA. Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and a music audiotape. J Travel Med 2003; 10 (2) 108-111
64 Yen Pik Sang FD, Golding JF, Gresty MA. Suppression of sickness by controlled breathing during mildly nauseogenic motion. Aviat Space Environ Med 2003; 74 (9) 998-1002
65 Ziavra NV, Yen Pik Sang FD, Golding JF, Bronstein AM, Gresty MA. Effect of breathing supplemental oxygen on motion sickness in healthy adults. Mayo Clin Proc 2003; 78 (5) 574-578
66 Chu H, Li MH, Juan SH, Chiou WY. Effects of transcutaneous electrical nerve stimulation on motion sickness induced by rotary chair: a crossover study. J Altern Complement Med 2012; 18 (5) 494-500
67 Miller KE, Muth ER. Efficacy of acupressure and acustimulation bands for the prevention of motion sickness. Aviat Space Environ Med 2004; 75 (3) 227-234
68 Golding JF, Prosyanikova O, Flynn M, Gresty MA. The effect of smoking nicotine tobacco versus smoking deprivation on motion sickness. Auton Neurosci 2011; 160 (1-2) 53-58
69 Lien HC, Sun WM, Chen YH, Kim H, Hasler W, Owyang C. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol 2003; 284 (3) G481-G489
70 Levine ME, Muth ER, Williamson MJ, Stern RM. Protein-predominant meals inhibit the development of gastric tachyarrhythmia, nausea and the symptoms of motion sickness. Aliment Pharmacol Ther 2004; 19 (5) 583-590
71 Lindseth G, Lindseth PD. The relationship of diet to airsickness. Aviat Space Environ Med 1995; 66 (6) 537-541
72 Wood CD, Graybiel A. Evaluation of 16 antimotion sickness drugs under controlled laboratory conditions. Aerosp Med 1969; 39: 1341-1344
73 Levine ME, Chillas JC, Stern RM, Knox GW. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness. Aviat Space Environ Med 2000; 71 (11) 1111-1114
74 Reid K, Palmer JL, Wright RJ , et al. Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man. Br J Clin Pharmacol 2000; 50 (1) 61-64
75 Hoyt RE, Lawson BD, McGee HA, Strompolis ML, McClellan MA. Modafinil as a potential motion sickness countermeasure. Aviat Space Environ Med 2009; 80 (8) 709-715
76 Stewart JJ, Wood MJ, Parish RC, Wood CD. Prokinetic effects of erythromycin after antimotion sickness drugs. J Clin Pharmacol 2000; 40 (4) 347-353
77 Nachum Z, Shahal B, Shupak A , et al. Scopolamine bioavailability in combined oral and transdermal delivery. J Pharmacol Exp Ther 2001; 296 (1) 121-123
78 Gil A, Nachum Z, Dachir S , et al. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors. Aviat Space Environ Med 2005; 76 (8) 766-770
79 Simmons RG, Phillips JB, Lojewski RA, Wang Z, Boyd JL, Putcha L. The efficacy of low-dose intranasal scopolamine for motion sickness. Aviat Space Environ Med 2010; 81 (4) 405-412
80 Golding JF. Motion sickness susceptibility. Auton Neurosci 2006; 129 (1-2) 67-76
81 Golding JF, Stott JRR. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol 1997; 43 (6) 633-637
82 Page NGR, Gresty MA. Motorist's vestibular disorientation syndrome. J Neurol Neurosurg Psychiatry 1985; 48 (8) 729-735
83 Gresty MA, Ohlmann TH. Motorists' vestibular disorientation syndrome revisited. RTO/NATO. RT-MPO-086. Spatial Disorientation in Military Vehicles, Causes, Consequences and Cures 2003; 13 (7) 1-13
84 Research and Technology Organizations (RTO), Human Factors and Medicine Panel (HFM). Spatial Disorientation in Military Vehicles: Causes, Consequences and Cures. North Atlantic Treaty Organization (NATO) RTO-MP-086, AC/323(HFM-085)TP/42. Brussels, Belgium: NATO; 2003
85 Brandt T, Huppert D, Dieterich M. Phobic postural vertigo: a first follow-up. J Neurol 1994; 241 (4) 191-195
86 Brandt T. Phobic postural vertigo. Neurology 1996; 46 (6) 1515-1519
87 St George RJ, Fitzpatrick RC. The sense of self-motion, orientation and balance explored by vestibular stimulation. J Physiol 2011; 589 (Pt 4) 807-813
88 Golding JF, Gresty MA. Motion sickness and disorientation in vehicles. In: Bronstein AM, , ed. Oxford Textbook of Vertigo and Imbalance. Oxford, England: Oxford University Press; 2013: 293-305
89 Lichtenberg BK, Young LR, Arrott AP. Human ocular counterrolling induced by varying linear accelerations. Exp Brain Res 1982; 48 (1) 127-136
90 Dichgans J, Held R, Young LR, Brandt T. Moving visual scenes influence the apparent direction of gravity. Science 1972; 178 (4066) 1217-1219
91 Previc FH, Kenyon RV, Boer ER, Johnson BH. The effects of background visual roll stimulation on postural and manual control and self-motion perception. Percept Psychophys 1993; 54 (1) 93-107
92 Wertheim AH, Mesland BS, Bles W. Cognitive suppression of tilt sensations during linear horizontal self-motion in the dark. Perception 2001; 30 (6) 733-741
93 Probst T, Straube A, Bles W. Differential effects of ambivalent visual-vestibular-somatosensory stimulation on the perception of self-motion. Behav Brain Res 1985; 16 (1) 71-79
94 William J. Perception. In: Psychology, The Briefer Course. Reproduced Toronto, Canada: Dover; 2001: 187–188. Originally published by Henry Holt, New York, NY; 1892
95 Mogg K, Bradley BP. A cognitive-motivational analysis of anxiety. Behav Res Ther 1998; 36 (9) 809-848 Review
96 Dobie TG, May JG. Cognitive-behavioral management of motion sickness. Aviat Space Environ Med 1994; 65 (10 Pt 2) C1-C2 Review
97 Benson AJ. Spatial disorientation—common illusions. In: Ernsting J, Nicholson AN, Rainford DJ, , eds. Aviation Medicine. 3rd ed. Oxford, England: Butterworth Heinemann; 1999: 437-454
98 Reid GE. Aviation psychiatry. In: Ernsting J, Nicholson AN, Rainford DJ, , eds. Aviation Medicine. 3rd ed. Oxford, England: Butterworth Heinemann; 1999: 397-416
99 Gresty MA, Waters S, Bray A, Bunday K, Golding JF. Impairment of spatial cognitive function with preservation of verbal performance during spatial disorientation. Curr Biol 2003; 13 (21) R829-R830